NCT02111603
Ability of Mayo Clinic High-performance Liquid Chromatography (HPLC) Method to Measure Fecal Bile Acids treatment 4 completed NCT01896583
A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) No drug interventions treatment 2 completed NCT01373034
The Effects of Soy Dietary Fiber in Adults With Diarrhea Predominant Irritable Bowel Syndrome No drug interventions treatment Not Available unknown_status NCT00616200
Effects of a Very Low Carbohydrate Diet on Symptoms of Irritable Bowel Syndrome (IBS) No drug interventions treatment Not Available completed NCT06346847
Study to Assess Effects of Postbiotic vs Placebo in Participants With Diarrhea-predominant IBS No drug interventions treatment Not Available not_yet_recruiting NCT04095988
Allogeneic Microbiota-reconstitution (AMR) in Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) No drug interventions treatment Not Available unknown_status NCT01350570
Acupuncture for Patients With Diarrhea-predominant IBS or Functional Diarrhea: a Randomized Controlled Trial treatment 2 / 3 completed NCT05687435
Changyanning Tablet for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) No drug interventions treatment 2 / 3 not_yet_recruiting NCT02251483
Use of SBI in IBS Subjects Following a Successful Treatment of Small Intestinal Bacterial Overgrowth No drug interventions supportive_care Not Available completed NCT02358694
Safety and Tolerability of Serum Derived Bovine Immunoglobulin in Children With Diarrhea Predominant IBS No drug interventions supportive_care Not Available completed NCT02190526
Effects of Mesalamine and Amitriptyline on Irritable Bowel Syndrome treatment 4 withdrawn NCT01637714
The Effects of Multi-strain Probiotics in Adults With Diarrhea Predominant Irritable Bowel Syndrome No drug interventions treatment Not Available unknown_status NCT01100684
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) treatment 3 completed NCT01414244
Glutamine for the Treatment of Patients With Irritable Bowel Syndrome treatment 2 completed NCT05593367
Effects of Vitamin D on Gut Microbiota, Intestinal Barrier in IBS-D Patients No drug interventions Not Available Not Available recruiting NCT01870895
A Study to Assess the Efficacy and Safety of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS) treatment 3 completed NCT03977155
Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) No drug interventions treatment 2 completed NCT05369884
Efficacy and Safety of WPQW Granule for Overlap of NERD and IBS-D No drug interventions treatment 0 unknown_status NCT03099785
Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With IBS-D treatment 2 completed NCT02612649
Special Drug Use Surveillance of Irribow in Female Patients Not Available Not Available completed NCT02163213
Serum-Derived Bovine Immunoglobulin /Protein Isolate (SBI) 5.0 g Bid on Nutritional Status in Subjects With IBS-D No drug interventions supportive_care Not Available completed NCT02728063
Lactibiane Tolérance® in Individuals Suffering From Irritable Bowel Syndrome With Diarrheal Predominance No drug interventions treatment Not Available completed NCT02239926
Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-D treatment 2 / 3 terminated NCT01094041
Gluten Intolerance in Patients With Diarrhea Predominant Irritable Bowel Syndrome No drug interventions treatment Not Available completed NCT02538692
Tong-Xie-Yao-Fang Granules for Diarrhea-predominant Irritable Bowel Syndrome treatment 2 / 3 completed NCT01736423
A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome treatment 3 completed NCT01358708
Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) With LACTEOL® 340 mg treatment 3 terminated NCT00619125
Proposal Evaluating Time-specific Relationships Between Variables of Pain, Stress, and Bloating in IBS Diarrhea and Constipation Symptoms Using a Palm Pilot No drug interventions Not Available Not Available completed NCT04855799
GI Permeability Change in Response to Aquamin® No drug interventions treatment 2 active_not_recruiting NCT06153420
Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D). No drug interventions treatment 2 recruiting NCT06612411
B.Subtilis Attenuate Symptoms in Diarrhea-predominant Irritable Bowel Syndrome by Increasing Hypoxanthine Biosynthesis No drug interventions treatment 0 recruiting NCT04053790
Lactobacillus LB as Treatment for Irritable Bowel Syndrome With Predominance of Diarrhea (IBS-D) treatment 4 completed NCT03221790
Effect of FODMAPs on Mucosal Inflammation in IBS Patients No drug interventions basic_science Not Available unknown_status NCT06297421
Efficacy and Safety of FMT for the Treatment of IBS-D and Mental Health Comorbidity in Young Adults No drug interventions treatment 2 not_yet_recruiting NCT02431533
The Efficacy of PX0612 In The Treatment Of Irritable Bowel Syndrome No drug interventions treatment Not Available completed NCT05754177
Safety and Efficacy of a Probiotic Supplement in IBS-D No drug interventions supportive_care Not Available recruiting NCT06543498
The Effect of Dietary Supplementation on Intestinal Barrier Function in IBS-D No drug interventions treatment Not Available not_yet_recruiting NCT02959983
Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide Use treatment 4 completed NCT05277428
Clinical Study to Evaluate the IBS Symptoms Improving Effect and Safety of GTB1 No drug interventions other Not Available completed NCT01543178
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study treatment 3 completed NCT03270085
Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption other 2 completed NCT04557215
Efficacy and Safety of Rifaximin With NAC in IBS-D treatment 1 / 2 completed NCT04214470
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in IBS No drug interventions Not Available Not Available unknown_status NCT05379036
Intestinal Permeability and Intestinal Microbiota in Irritable Bowel Syndrome No drug interventions treatment 4 unknown_status NCT02320318
12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D) treatment 3 withdrawn NCT02822118
Therapeutic Effect of Chang'an I Recipe on Irritable Bowel Syndrome With Diarrhea No drug interventions treatment 1 / 2 completed NCT04129619
A Comparison of the Effects of ORP-101 Versus Placebo in Adult Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D) treatment 2 completed NCT05453916
Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation treatment 1 / 2 recruiting NCT04806386
The Role of Fiber in the Prevention and Treatment of Fecal Incontinence No drug interventions treatment Not Available recruiting NCT04662957
Multi Strain Probiotic Preparation in Patients With Irritable Bowel Syndrome No drug interventions treatment Not Available completed NCT03441581
Eluxadoline Bile Acid Malabsorption (BAM) Study treatment 4 completed NCT05702255
Self- Administered Acupressure for Diarrhea Predominant Irritable Bowel Syndrome No drug interventions supportive_care Not Available completed NCT05867550
To Compare the Efficacy of Drugs in Combination for Treating Irritable Bowel Syndrome Associated With Diarrhea treatment 4 completed NCT04492787
Efficacy and Safety of Changkang Granule in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) No drug interventions treatment 2 completed NCT01497847
Post-Infectious Irritable Bowel Syndrome (PI-IBS) No drug interventions Not Available Not Available completed NCT05130047
Aldafermin (NGM282) for Chronic Diarrhea Due to Bile Acid Malabsorption (BAM) treatment 2 completed NCT03245645
FODMAP Reintroduction in Irritable Bowel Syndrome No drug interventions treatment Not Available completed NCT02757105
Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) treatment 2 completed NCT05311293
Study on the Molecular Mechanism of Diarrhea-predominant Irritable Bowel Syndrome With Anxiety and Depression Based on Multi-omics Correlation Analysis No drug interventions Not Available Not Available unknown_status NCT03729271
Hydrogen Breath Test an Instrument to Predict Rifaximin-Response in Irritable Bowel Syndrome Predominant Diarrhea treatment 4 recruiting NCT03557788
Changes in Microbiota and Metabolomic Profile Between Rifaximin Responders and Non-responders In Diarrhoea-Predominant Irritable Bowel Syndrome basic_science 4 completed NCT03806959
Interest of Pan Capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy No drug interventions diagnostic Not Available completed NCT01303224
Ibodutant for Relief of Irritable Bowel Syndrome With Diarrhoea (IBS-D) treatment 2 completed NCT02107196
12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D) treatment 3 completed NCT04950296
To Study the Efficacy and Safety of L. Plantarum UALp-05TM in Diarrhea- Predominant-irritable Bowel Syndrome No drug interventions other Not Available completed NCT05719896
Efficacy and Safety of DT01 Tablets in Patients With Irritable Bowel Syndrome With Diarrhea No drug interventions treatment 2 not_yet_recruiting NCT05646186
Personalized Dietary Intervention Based on Microbiome Analysis vs FODMAP Diet for Irritable Bowel Syndrome No drug interventions treatment Not Available unknown_status NCT00552565
Efficacy Study of Rezular (Arverapamil) in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D) treatment 3 completed NCT02120027
52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D) treatment 3 terminated NCT05523427
Probiotics as Adjuvant Therapy in the Management of Irritable Bowel Syndrome No drug interventions treatment Not Available completed NCT04484467
Efficacy and Safety of a Food Supplement With Standardized Menthol, Limonene, and Gingerol Content in Patients With Irritable Bowel Syndrome No drug interventions treatment Not Available completed NCT04899869
Faecal Microbiota Transplantation in Irritable Bowel Syndrome No drug interventions treatment Not Available completed NCT06432569
Evaluation of Butyrate and Palmitoylethanolamide in IBS Patients (B/P3_1) No drug interventions treatment Not Available enrolling_by_invitation NCT06247046
A Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Patients With IBS-D No drug interventions treatment 3 recruiting NCT04830410
The Effects of Carbohydrates in Irritable Bowel Syndrome No drug interventions treatment Not Available recruiting NCT01177410
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea treatment 2 completed NCT03997708
A Mediterranean Approach to Low FODMAP Diet (MED-LFD) for Managing IBS Symptoms No drug interventions supportive_care Not Available completed NCT05339243
Evaluating the Safety and Efficacy of the Probiotic Bifidobacterium Longum ES1 and the Post Biotic Heat-treated Bifidobacterium Longum ES1 (HT-ES1) on IBS Symptom Severity in Patients With Diarrhoea Predominant Irritable Bowel Syndrome No drug interventions other Not Available completed NCT02419963
Analyzing IBS to Identify Biomarkers and Microbiome Signatures No drug interventions basic_science Not Available completed NCT02661425
Retrospective Study of IBS-D Patients Previously Receiving SBI No drug interventions Not Available Not Available completed NCT00589771
Saccharomyces Boulardii in Irritable Bowel Syndrome No drug interventions treatment 3 completed